Multiplicity in randomised trials II: subgroup and interim analyses
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Subgroup analyses can pose serious multiplicity concerns. By testing enough subgroups, a false-positive result will probably emerge by chance alone. Investigators might undertake many analyses but only report the significant effects, distorting the medical literature. In general, we discourage subgroup analyses. However, if they are necessary, researchers should do statistical tests of interaction, rather than analyse every separate subgroup. Investigators cannot avoid interim analyses when data monitoring is indicated. However, repeatedly testing at every interim raises multiplicity concerns, and not accounting for multiplicity escalates the false-positive error. Statistical stopping methods must be used. The O'Brien-Fleming and Peto group sequential stopping methods are easily implemented and preserve the intended alpha level and power. Both adopt stringent criteria (low nominal p values) during the interim analyses. Implementing a trial under these stopping rules resembles a conventional trial, with the exception that it can be terminated early should a treatment prove greatly superior. Investigators and readers, however, need to grasp that the estimated treatment effects are prone to exaggeration, a random high, with early stopping.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Practices that can lead to P-hacking include an interim analysis to decide whether an experiment or a study should be stopped prematurely (21), as well as post hoc excluding of outliers from the analysis, deciding to combine or split groups, adjusting covariates, performing subgroup analysis (22), or choosing the threshold for dichotomizing continuous outcomes.”
From Misrepresentation and distortion of research in biomedical literature (2018) · cites this paper as [22]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 31 · Cited by 357
Metadata
- Authors
- Schulz, K. F., & Grimes, D. A.
- Affiliations
- Family Health International 360 (US)
- Corresponding author
- Schulz, Kenneth F
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 365
- Issue
- 9471
- Pages
- 1657-1661
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2126919203
- Cited by
- 357
- References
- 31
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 19 · 2023: 11 · 2022: 17 · 2021: 19 · 2020: 39 · 2019: 17 · 2018: 9 · 2017: 13 · 2016: 23 · 2015: 15 · 2014: 15 · 2013: 14 · 2012: 14
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Research England
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Keywords
- multiplicity, subgroup analysis, interim analysis, false positives, data monitoring, early trial termination, treatment effect estimation
- MeSH terms
- Data Interpretation, Statistical, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiplicity in randomised trials II: subgroup and interim analyses. https://app.cochat.ai/papers/10.1016/s0140-6736(05)66516-6
- The paper
- Schulz, K. F., & Grimes, D. A. (2005). Multiplicity in randomised trials II: subgroup and interim analyses. The Lancet. https://doi.org/10.1016/s0140-6736(05)66516-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.